20 (AIDX) Operating Margin (2025 - 2026)
20's (AIDX) quarterly Operating Margin came in at 170.31% in Q2 2026, down 1226.0% on a YoY basis from 15.13% in Q2 2025, and up 58.3% quarter-over-quarter from 408.45% in Q1 2026.
Powered by 
Analysis
20 (AIDX) Operating Margin (2025 - 2026) Analysis & Trends
20 (AIDX) has reported Operating Margin for 2 consecutive years, with 170.31% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Margin fell 1226.0% year-over-year to 170.31%; the trailing twelve-month figure through Jun 2026 stood at 198.15% (changed N/A YoY), and the FY2025 full-year result was 162.87%, up 16112.0% from the prior year.
- Operating Margin grew to 170.31% in Q2 2026 per AIDX's latest filing, from 408.45% in the prior quarter.
- Across five years, Operating Margin topped out at 139.43% in Q1 2025 and bottomed at 408.45% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.12 Bn | 46.02 Bn | 486.15 Mn | -10.07% |
| 2 | Labcorp Holdings | 26.25 Bn | 26.10 Bn | 1.11 Bn | 12.10% |
| 3 | Quest Diagnostics | 26.02 Bn | 25.40 Bn | 1.03 Bn | 15.08% |
| 4 | Guardant Health | 21.89 Bn | 20.84 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 11.21 Bn | 10.39 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 6.94 Bn | 6.14 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.22 Bn | 4.86 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.75 Bn | 4.20 Bn | 77.11 Mn | 5.03% |
| 9 | iRhythm Holdings | 3.98 Bn | 3.39 Bn | 163.21 Mn | -1.13% |
| 10 | 20 | 6.09 Mn | 1.55 Mn | 304,727.00 | -170.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -170.31% |
| Mar 31, 2026 | -408.45% |
| Jun 30, 2025 | -158.05% |
| Mar 31, 2025 | -139.43% |